-
-
-
-
-
-
-
Takeda reports 7-year dengue vaccine data showing sustained protection
-
-
-
-
-
-
-
FDA Advisory Committee Recommends Use of Investigational Drug Maribavir (TAK-620) to Treat Post-Transplant Recipients with Cytomegalovirus (CMV) Infection and Disease Refractory to Treatment With or W
-
-
-
-
-
-
-
Takeda to Present Data at Upcoming Virtual Scientific Congresses, Underscoring Breadth of Oncology Portfolio and Emerging Pipeline
70,840 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

